APA (7th ed.) Citation

Engert, A., Ho, A. D., & Kratochwil, C. (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial. The lancet, 379(9828), . https://doi.org/10.1016/S0140-6736(11)61940-5

Chicago Style (17th ed.) Citation

Engert, Andreas, Anthony Dick Ho, and Clemens Kratochwil. "Reduced-intensity Chemotherapy and PET-guided Radiotherapy in Patients with Advanced Stage Hodgkin's Lymphoma (HD15 Trial): A Randomised, Open-label, Phase 3 Non-inferiority Trial." The Lancet 379, no. 9828 (2012). https://doi.org/10.1016/S0140-6736(11)61940-5.

MLA (9th ed.) Citation

Engert, Andreas, et al. "Reduced-intensity Chemotherapy and PET-guided Radiotherapy in Patients with Advanced Stage Hodgkin's Lymphoma (HD15 Trial): A Randomised, Open-label, Phase 3 Non-inferiority Trial." The Lancet, vol. 379, no. 9828, 2012, https://doi.org/10.1016/S0140-6736(11)61940-5.